| M9U | Name: | (4S)-6-chloro-N-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide | Formula: | C15 H15 Cl N4 O2 | SMILES: | Clc1ccc2OCCC(c2c1)C(=O)Nc1nncn1C1CC1 | InChi: | InChI=1S/C15H15ClN4O2/c16-9-1-4-13-12(7-9)11(5-6-22-13)14(21)18-15-19-17-8-20(15)10-2-3-10/h1,4,7-8,10-11H,2-3,5-6H2,(H,18,19,21)/t11-/m0/s1 | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (4S)-6-chloro-N-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide |
|
| MBQ | Name: | 2-HYDROXY-5-({1-[(4-METHYLPHENOXY)METHYL]-3-OXOPROP-1-ENYL}AMINO)-L-TYROSINE | Formula: | C20 H22 N2 O6 | SMILES: | O=C(O)C(N)Cc2c(O)cc(O)c(NC(=CC=O)COc1ccc(cc1)C)c2 | InChi: | InChI=1S/C20H22N2O6/c1-12-2-4-15(5-3-12)28-11-14(6-7-23)22-17-9-13(8-16(21)20(26)27)18(24)10-19(17)25/h2-7,9-10,16,22,24-25H,8,11,21H2,1H3,(H,26,27)/b14-6+/t16-/m0/s1 | Definition date: | 2004-03-04 | Last modified: | 2023-11-03 | Identifier: | 2-hydroxy-5-({(1E)-1-[(4-methylphenoxy)methyl]-3-oxoprop-1-en-1-yl}amino)-L-tyrosine |
|
| MDF | Name: | META, META'-DI-HYDROXY-PHENYLALANINE | Formula: | C9 H11 N O4 | SMILES: | O=C(OC)C(c1cc(O)cc(O)c1)N | InChi: | InChI=1S/C9H11NO4/c1-14-9(13)8(10)5-2-6(11)4-7(12)3-5/h2-4,8,11-12H,10H2,1H3/t8-/m0/s1 | Definition date: | 2002-09-02 | Last modified: | 2023-11-03 | Identifier: | methyl (2S)-amino(3,5-dihydroxyphenyl)ethanoate |
|
| MDO | Name: | {2-[(1S)-1-aminoethyl]-4-methylidene-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid | Formula: | C8 H11 N3 O3 | SMILES: | O=C1C(N=C(N1CC(=O)O)C(N)C)=C | InChi: | InChI=1S/C8H11N3O3/c1-4(9)7-10-5(2)8(14)11(7)3-6(12)13/h4H,2-3,9H2,1H3,(H,12,13)/t4-/m0/s1 | Synonyms: | 4-METHYLIDENE-5-ONE | Definition date: | 2001-08-15 | Last modified: | 2023-11-03 | Identifier: | {2-[(1S)-1-aminoethyl]-4-methylidene-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
| MF0 | Name: | (2R)-2-(5-chloropyridin-3-yl)-N-(4-methylpyridin-3-yl)propanamide | Formula: | C14 H14 Cl N3 O | SMILES: | O=C(Nc1cnccc1C)C(C)c1cc(Cl)cnc1 | InChi: | InChI=1S/C14H14ClN3O/c1-9-3-4-16-8-13(9)18-14(19)10(2)11-5-12(15)7-17-6-11/h3-8,10H,1-2H3,(H,18,19)/t10-/m1/s1 | Definition date: | 2023-08-15 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (2R)-2-(5-chloropyridin-3-yl)-N-(4-methylpyridin-3-yl)propanamide |
|
| MFC | Name: | 5-[1-(3-FLUORO-4-HYDROXY-PHENYL)-METH-(Z)-YLIDENE]-3,5-DIHYDRO-IMIDAZOL-4-ONE | Formula: | C15 H16 F N3 O5 | SMILES: | Fc1c(O)ccc(c1)C=C2/N=C(N(C2=O)CC(=O)O)C(N)C(O)C | InChi: | InChI=1S/C15H16FN3O5/c1-7(20)13(17)14-18-10(15(24)19(14)6-12(22)23)5-8-2-3-11(21)9(16)4-8/h2-5,7,13,20-21H,6,17H2,1H3,(H,22,23)/b10-5-/t7-,13+/m1/s1 | Definition date: | 2004-01-05 | Last modified: | 2023-11-03 | Identifier: | {(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-[(3-fluoro-4-hydroxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
| MFD | Name: | (2S,3S,8S,9S)-3-AMINO-9-METHOXY-2,6,8-TRIMETHYL-10-PHENYLDECA-4,6-DIENOIC ACID | Formula: | C20 H29 N O3 | SMILES: | O=C(O)C(C)C(N)/C=C/C(=C/C(C(OC)Cc1ccccc1)C)C | InChi: | InChI=1S/C20H29NO3/c1-14(10-11-18(21)16(3)20(22)23)12-15(2)19(24-4)13-17-8-6-5-7-9-17/h5-12,15-16,18-19H,13,21H2,1-4H3,(H,22,23)/b11-10+,14-12+/t15-,16+,18+,19-/m1/s1 | Definition date: | 1999-08-05 | Last modified: | 2023-11-03 | Identifier: | (2S,3S,4E,6E,8R,9R)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid |
|
| MFH | Name: | [(2~{S})-2-azanyl-3-(4-hydroxyphenyl)propyl]carbamic acid | Formula: | C10 H14 N2 O3 | SMILES: | N[CH](CNC(O)=O)Cc1ccc(O)cc1 | InChi: | InChI=1S/C10H14N2O3/c11-8(6-12-10(14)15)5-7-1-3-9(13)4-2-7/h1-4,8,12-13H,5-6,11H2,(H,14,15)/t8-/m0/s1 | Definition date: | 2019-10-12 | Last modified: | 2023-11-03 | Release date: | 2021-02-17 | Identifier: | [(2~{S})-2-azanyl-3-(4-hydroxyphenyl)propyl]carbamic acid |
|
| MFV | Name: | {(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-[(4-hydroxy-3-methylphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid | Formula: | C16 H19 N3 O5 | SMILES: | NC(C(O)C)C1=N/C(C(N1CC(O)=O)=O)=Cc2cc(C)c(cc2)O | InChi: | InChI=1S/C16H19N3O5/c1-8-5-10(3-4-12(8)21)6-11-16(24)19(7-13(22)23)15(18-11)14(17)9(2)20/h3-6,9,14,20-21H,7,17H2,1-2H3,(H,22,23)/b11-6-/t9-,14+/m1/s1 | Synonyms: | PEPTIDE DERIVED CHROMOPHORE | Definition date: | 2019-04-02 | Last modified: | 2023-11-03 | Release date: | 2019-07-10 | Identifier: | {(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-[(4-hydroxy-3-methylphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
| MGG | Name: | 2-(2-CARBOXY-ACETYLAMINO)-5-GUANIDINO-PENTANOIC ACID | Formula: | C9 H17 N4 O5 | SMILES: | O=C(NC(C(=O)O)CCCNC(=[NH2+])N)CC(=O)O | InChi: | InChI=1S/C9H16N4O5/c10-9(11)12-3-1-2-5(8(17)18)13-6(14)4-7(15)16/h5H,1-4H2,(H,13,14)(H,15,16)(H,17,18)(H4,10,11,12)/p+1/t5-/m1/s1 | Synonyms: | D-ARGININE WITH 3-OXO-PROPIONIC ACID MODIFICATION | Definition date: | 1999-08-25 | Last modified: | 2023-11-03 | Identifier: | amino({(4R)-4-carboxy-4-[(carboxyacetyl)amino]butyl}amino)methaniminium |
|
| MHU | Name: | 4-N,N-(DIMETHYLAMINO)-L-PHENYLALANINE | Formula: | C12 H18 N2 O2 | SMILES: | O=C(O)C(NC)Cc1ccc(N(C)C)cc1 | InChi: | InChI=1S/C12H18N2O2/c1-13-11(12(15)16)8-9-4-6-10(7-5-9)14(2)3/h4-7,11,13H,8H2,1-3H3,(H,15,16)/t11-/m0/s1 | Definition date: | 2010-07-15 | Last modified: | 2023-11-03 | Identifier: | 4-(dimethylamino)-N-methyl-L-phenylalanine |
|
| MHY | Name: | {(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-[(3,5-difluoro-4-hydroxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid | Formula: | C15 H15 F2 N3 O5 | SMILES: | NC(C1=N/C(C(N1CC(O)=O)=O)=Cc2cc(F)c(c(c2)F)O)C(O)C | InChi: | InChI=1S/C15H15F2N3O5/c1-6(21)12(18)14-19-10(15(25)20(14)5-11(22)23)4-7-2-8(16)13(24)9(17)3-7/h2-4,6,12,21,24H,5,18H2,1H3,(H,22,23)/b10-4-/t6-,12+/m1/s1 | Definition date: | 2019-04-02 | Last modified: | 2023-11-03 | Release date: | 2020-04-08 | Identifier: | {(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-[(3,5-difluoro-4-hydroxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
| MJ1 | Name: | {(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-[(2,3-difluoro-4-hydroxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid | Formula: | C15 H15 F2 N3 O5 | SMILES: | C1(=NC(C(N1CC(O)=O)=O)=[C@H]c2c(c(F)c(cc2)O)F)C(C(O)C)N | InChi: | InChI=1S/C15H15F2N3O5/c1-6(21)13(18)14-19-8(15(25)20(14)5-10(23)24)4-7-2-3-9(22)12(17)11(7)16/h2-4,6,13,21-22H,5,18H2,1H3,(H,23,24)/b8-4-/t6-,13+/m1/s1 | Definition date: | 2019-04-02 | Last modified: | 2023-11-03 | Release date: | 2020-04-08 | Identifier: | {(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-[(2,3-difluoro-4-hydroxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
| MJR | Name: | 2-(3-chlorophenyl)-N-(3-methyl-1H-pyrazol-4-yl)acetamide | Formula: | C12 H12 Cl N3 O | SMILES: | O=C(Nc1c[NH]nc1C)Cc1cccc(Cl)c1 | InChi: | InChI=1S/C12H12ClN3O/c1-8-11(7-14-16-8)15-12(17)6-9-3-2-4-10(13)5-9/h2-5,7H,6H2,1H3,(H,14,16)(H,15,17) | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chlorophenyl)-N-(3-methyl-1H-pyrazol-4-yl)acetamide |
|
| MKI | Name: | 2-(3-chlorophenyl)-N-methyl-N-(4-methylpyridin-3-yl)acetamide | Formula: | C15 H15 Cl N2 O | SMILES: | Cc1ccncc1N(C)C(=O)Cc1cccc(Cl)c1 | InChi: | InChI=1S/C15H15ClN2O/c1-11-6-7-17-10-14(11)18(2)15(19)9-12-4-3-5-13(16)8-12/h3-8,10H,9H2,1-2H3 | Definition date: | 2023-08-16 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chlorophenyl)-N-methyl-N-(4-methylpyridin-3-yl)acetamide |
|
| AY0 | Name: | (1R,2R,3S)-2-(methylcarbamoyl)-3-[4-(phosphonooxy)phenyl]cyclopropanecarboxylic acid | Formula: | C12 H14 N O7 P | SMILES: | O=C(NC)C2C(c1ccc(OP(=O)(O)O)cc1)C2C(=O)O | InChi: | InChI=1S/C12H14NO7P/c1-13-11(14)9-8(10(9)12(15)16)6-2-4-7(5-3-6)20-21(17,18)19/h2-5,8-10H,1H3,(H,13,14)(H,15,16)(H2,17,18,19)/t8-,9+,10+/m0/s1 | Definition date: | 2010-10-09 | Last modified: | 2023-11-03 | Identifier: | (1R,2R,3S)-2-(methylcarbamoyl)-3-[4-(phosphonooxy)phenyl]cyclopropanecarboxylic acid |
|
| B2C | Name: | {(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-[(3-bromo-4-hydroxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid | Formula: | C15 H16 Br N3 O5 | SMILES: | C(O)(C)C(C2=NC(=[C@H]c1cc(Br)c(cc1)O)C(N2CC(O)=O)=O)N | InChi: | InChI=1S/C15H16BrN3O5/c1-7(20)13(17)14-18-10(15(24)19(14)6-12(22)23)5-8-2-3-11(21)9(16)4-8/h2-5,7,13,20-21H,6,17H2,1H3,(H,22,23)/b10-5-/t7-,13+/m1/s1 | Definition date: | 2019-04-02 | Last modified: | 2023-11-03 | Release date: | 2020-04-08 | Identifier: | {(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-[(3-bromo-4-hydroxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
| B2H | Name: | Chromophore (Thr, Trp, Gly) | Formula: | C17 H20 N4 O4 | SMILES: | C[CH](O)[CH](N)c1nc(Cc2c[nH]c3ccccc23)c(O)n1CC(O)=O | InChi: | InChI=1S/C17H20N4O4/c1-9(22)15(18)16-20-13(17(25)21(16)8-14(23)24)6-10-7-19-12-5-3-2-4-11(10)12/h2-5,7,9,15,19,22,25H,6,8,18H2,1H3,(H,23,24)/t9-,15+/m1/s1 | Definition date: | 2017-09-06 | Last modified: | 2023-11-03 | Release date: | 2017-11-29 | Identifier: | 2-[2-[(1~{R},2~{R})-1-azanyl-2-oxidanyl-propyl]-4-(1~{H}-indol-3-ylmethyl)-5-oxidanyl-imidazol-1-yl]ethanoic acid |
|
| B3Y | Name: | (3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID | Formula: | C10 H13 N O3 | SMILES: | O=C(O)CC(N)Cc1ccc(O)cc1 | InChi: | InChI=1S/C10H13NO3/c11-8(6-10(13)14)5-7-1-3-9(12)4-2-7/h1-4,8,12H,5-6,11H2,(H,13,14)/t8-/m0/s1 | Definition date: | 2007-02-28 | Last modified: | 2023-11-03 | Identifier: | (3S)-3-amino-4-(4-hydroxyphenyl)butanoic acid |
|
| 51T | Name: | 2,3,6-trifluoro-L-tyrosine | Formula: | C9 H8 F3 N O3 | SMILES: | NC(Cc1c(cc(c(c1F)F)O)F)C(=O)O | InChi: | InChI=1S/C9H8F3NO3/c10-4-2-6(14)8(12)7(11)3(4)1-5(13)9(15)16/h2,5,14H,1,13H2,(H,15,16)/t5-/m0/s1 | Definition date: | 2015-07-13 | Last modified: | 2023-11-03 | Release date: | 2016-06-22 | Identifier: | 2,3,6-trifluoro-L-tyrosine |
|
| B8R | Name: | (2S,10R)-2,10-diamino-11-(dimethylamino)-11-oxoundecanoic acid | Formula: | C13 H27 N3 O3 | SMILES: | C(C(CCCCCCCC(N)C(=O)N(C)C)N)(=O)O | InChi: | InChI=1S/C13H27N3O3/c1-16(2)12(17)10(14)8-6-4-3-5-7-9-11(15)13(18)19/h10-11H,3-9,14-15H2,1-2H3,(H,18,19)/t10-,11+/m1/s1 | Definition date: | 2019-01-22 | Last modified: | 2023-11-03 | Release date: | 2019-02-13 | Identifier: | (2S,10R)-2,10-diamino-11-(dimethylamino)-11-oxoundecanoic acid |
|
| 54C | Name: | (betaR)-beta-hydroxy-1-{2-[(2R)-oxiran-2-yl]propan-2-yl}-L-tryptophan | Formula: | C16 H20 N2 O4 | SMILES: | C(C(=O)O)(N)C(c1cn(c2c1cccc2)C(C)(C)C3CO3)O | InChi: | InChI=1S/C16H20N2O4/c1-16(2,12-8-22-12)18-7-10(14(19)13(17)15(20)21)9-5-3-4-6-11(9)18/h3-7,12-14,19H,8,17H2,1-2H3,(H,20,21)/t12-,13-,14+/m0/s1 | Definition date: | 2015-07-23 | Last modified: | 2023-11-03 | Release date: | 2015-10-28 | Identifier: | (betaR)-beta-hydroxy-1-{2-[(2R)-oxiran-2-yl]propan-2-yl}-L-tryptophan |
|
| 55I | Name: | 4-(trifluoromethyl)-L-phenylalanine | Formula: | C10 H10 F3 N O2 | SMILES: | FC(F)(F)c1ccc(CC(N)C(=O)O)cc1 | InChi: | InChI=1S/C10H10F3NO2/c11-10(12,13)7-3-1-6(2-4-7)5-8(14)9(15)16/h1-4,8H,5,14H2,(H,15,16)/t8-/m0/s1 | Definition date: | 2021-07-16 | Last modified: | 2023-11-03 | Release date: | 2021-09-29 | Identifier: | 4-(trifluoromethyl)-L-phenylalanine |
|
| EXB | Name: | 3-(1H-benzimidazol-1-yl)propanoic acid | Formula: | C10 H10 N2 O2 | SMILES: | O=C(O)CCn1c2ccccc2nc1 | InChi: | InChI=1S/C10H10N2O2/c13-10(14)5-6-12-7-11-8-3-1-2-4-9(8)12/h1-4,7H,5-6H2,(H,13,14) | Definition date: | 2008-11-12 | Last modified: | 2023-11-03 | Identifier: | 3-(1H-benzimidazol-1-yl)propanoic acid |
|
| EXL | Name: | 1-Methyl-L-tryptophan | Formula: | C12 H14 N2 O2 | SMILES: | Cn1cc(C[CH](N)C(O)=O)c2ccccc12 | InChi: | InChI=1S/C12H14N2O2/c1-14-7-8(6-10(13)12(15)16)9-4-2-3-5-11(9)14/h2-5,7,10H,6,13H2,1H3,(H,15,16)/t10-/m0/s1 | Synonyms: | (2S)-2-azanyl-3-(1-methylindol-3-yl)propanoic acid | Definition date: | 2020-02-14 | Last modified: | 2023-11-03 | Release date: | 2020-07-08 | Identifier: | (2~{S})-2-azanyl-3-(1-methylindol-3-yl)propanoic acid |
|